Literature DB >> 31563843

Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: Implications in DNA repair and immune responses.

Pooja Mandke1, Karen M Vasquez2.   

Abstract

High mobility group box protein 1 (HMGB1) is a highly versatile, abundant, and ubiquitously expressed, non-histone chromosomal protein, which belongs to the HMGB family of proteins. These proteins form an integral part of the architectural protein repertoire to support chromatin structure in the nucleus. In the nucleus, the role of HMGB1 is attributed to its ability to bind to undamaged DNA, damaged DNA, and alternative (i.e. non-B) DNA structures with high affinity and subsequently induce bending of the DNA substrates. Due to its binding to DNA, HMGB1 has been implicated in critical biological processes, such as DNA transcription, replication, repair, and recombination. In addition to its intracellular functions, HMGB1 can also be released in the extracellular space where it elicits immunological responses. HMGB1 associates with many different molecules, including DNA, RNA, proteins, and lipopolysaccharides to modulate a variety of processes in both DNA metabolism and in innate immunity. In this review, we will focus on the implications of the interactions of HMGB1 with nucleic acids in DNA repair and immune responses. We report on the roles of HMGB1 in nucleotide excision repair (NER), base excision repair (BER), mismatch repair (MMR) and DNA double-strand break repair (DSBR). We also report on its roles in immune responses via its potential effects on antigen receptor diversity generation [V(D)J recombination] and interactions with foreign and self-nucleic acids. HMGB1 expression is altered in a variety of cancers and immunological disorders. However, due to the diversity and complexity of the biological processes influenced by HMGB1 (and its family members), a detailed understanding of the intracellular and extracellular roles of HMGB1 in DNA damage repair and immune responses is warranted to ensure the development of effective HMGB1-related therapies.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmunity; DNA damage; DNA repair; High mobility group box 1 protein (HMGB1); V(D)J recombination

Mesh:

Substances:

Year:  2019        PMID: 31563843      PMCID: PMC6906087          DOI: 10.1016/j.dnarep.2019.102701

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  112 in total

1.  Involvement of HMGB1 and HMGB2 proteins in exogenous DNA integration reaction into the genome of HeLa S3 cells.

Authors:  Tetsuya Ueda; Hitoshi Shirakawa; Michiteru Yoshida
Journal:  Biochim Biophys Acta       Date:  2002-12-16

2.  Global nature of dynamic protein-chromatin interactions in vivo: three-dimensional genome scanning and dynamic interaction networks of chromatin proteins.

Authors:  Robert D Phair; Paola Scaffidi; Cem Elbi; Jaromíra Vecerová; Anup Dey; Keiko Ozato; David T Brown; Gordon Hager; Michael Bustin; Tom Misteli
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 3.  HMGB proteins: interactions with DNA and chromatin.

Authors:  Michal Stros
Journal:  Biochim Biophys Acta       Date:  2010 Jan-Feb

4.  Human XPA and RPA DNA repair proteins participate in specific recognition of triplex-induced helical distortions.

Authors:  Karen M Vasquez; Jesper Christensen; Lei Li; Rick A Finch; Peter M Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

5.  Coordination between polymerase beta and FEN1 can modulate CAG repeat expansion.

Authors:  Yuan Liu; Rajendra Prasad; William A Beard; Esther W Hou; Julie K Horton; Cynthia T McMurray; Samuel H Wilson
Journal:  J Biol Chem       Date:  2009-08-11       Impact factor: 5.157

6.  A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA.

Authors:  Stanimir Ivanov; Ana-Maria Dragoi; Xin Wang; Corrado Dallacosta; Jennifer Louten; Giovanna Musco; Giovanni Sitia; George S Yap; Yinsheng Wan; Christine A Biron; Marco E Bianchi; Haichao Wang; Wen-Ming Chu
Journal:  Blood       Date:  2007-06-04       Impact factor: 22.113

7.  V(D)J recombination: modulation of RAG1 and RAG2 cleavage activity on 12/23 substrates by whole cell extract and DNA-bending proteins.

Authors:  D J Sawchuk; F Weis-Garcia; S Malik; E Besmer; M Bustin; M C Nussenzweig; P Cortes
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

8.  HMGB1/2 can target DNA for illegitimate cleavage by the RAG1/2 complex.

Authors:  Ming Zhang; Patrick C Swanson
Journal:  BMC Mol Biol       Date:  2009-03-24       Impact factor: 2.946

9.  Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.

Authors:  Vilma Urbonaviciute; Barbara G Fürnrohr; Silke Meister; Luis Munoz; Petra Heyder; Francesco De Marchis; Marco E Bianchi; Carsten Kirschning; Hermann Wagner; Angelo A Manfredi; Joachim R Kalden; Georg Schett; Patrizia Rovere-Querini; Martin Herrmann; Reinhard E Voll
Journal:  J Exp Med       Date:  2008-12-08       Impact factor: 14.307

10.  RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA.

Authors:  Cherilyn M Sirois; Tengchuan Jin; Allison L Miller; Damien Bertheloot; Hirotaka Nakamura; Gabor L Horvath; Abubakar Mian; Jiansheng Jiang; Jacob Schrum; Lukas Bossaller; Karin Pelka; Natalio Garbi; Yambasu Brewah; Jane Tian; ChewShun Chang; Partha S Chowdhury; Gary P Sims; Roland Kolbeck; Anthony J Coyle; Alison A Humbles; T Sam Xiao; Eicke Latz
Journal:  J Exp Med       Date:  2013-09-30       Impact factor: 14.307

View more
  27 in total

1.  High-mobility group box1 as an amplifier of immune response and target for treatment in Aspergillus fumigatus keratitis.

Authors:  Meng-Qi Wu; Cui Li; Li-Na Zhang; Jing Lin; Kun He; Ya-Wen Niu; Cheng-Ye Che; Nan Jiang; Jia-Qian Jiang; Gui-Qiu Zhao
Journal:  Int J Ophthalmol       Date:  2020-05-18       Impact factor: 1.779

2.  HMGB1-mediated chromatin remodeling attenuates Il24 gene expression for the protection from allergic contact dermatitis.

Authors:  Naoyuki Senda; Hideyuki Yanai; Sana Hibino; Lei Li; Yu Mizushima; Tomomitsu Miyagaki; Mai Saeki; Yusuke Kishi; Sho Hangai; Junko Nishio; Makoto Sugaya; Tadatsugu Taniguchi; Shinichi Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-05       Impact factor: 11.205

3.  A minimal motif for sequence recognition by mitochondrial transcription factor A (TFAM).

Authors:  Woo Suk Choi; Miguel Garcia-Diaz
Journal:  Nucleic Acids Res       Date:  2022-01-11       Impact factor: 16.971

4.  O-GlcNAcylation of High Mobility Group Box 1 (HMGB1) Alters Its DNA Binding and DNA Damage Processing Activities.

Authors:  Aaron T Balana; Anirban Mukherjee; Harsh Nagpal; Stuart P Moon; Beat Fierz; Karen M Vasquez; Matthew R Pratt
Journal:  J Am Chem Soc       Date:  2021-09-21       Impact factor: 16.383

Review 5.  Targeting Chromosomal Architectural HMGB Proteins Could Be the Next Frontier in Cancer Therapy.

Authors:  Anirban Mukherjee; Karen M Vasquez
Journal:  Cancer Res       Date:  2020-03-09       Impact factor: 12.701

6.  Intratumoral SIRPα-deficient macrophages activate tumor antigen-specific cytotoxic T cells under radiotherapy.

Authors:  Zhen Bian; Lei Shi; Koby Kidder; Ke Zen; Charlie Garnett-Benson; Yuan Liu
Journal:  Nat Commun       Date:  2021-05-28       Impact factor: 14.919

7.  Dynamic Autoinhibition of the HMGB1 Protein via Electrostatic Fuzzy Interactions of Intrinsically Disordered Regions.

Authors:  Xi Wang; Harry M Greenblatt; Lavi S Bigman; Binhan Yu; Channing C Pletka; Yaakov Levy; Junji Iwahara
Journal:  J Mol Biol       Date:  2021-06-25       Impact factor: 6.151

Review 8.  Using PAMPs and DAMPs as adjuvants in cancer vaccines.

Authors:  Huanyou Sun; Wenwen Hu; Yinan Yan; Zichun Zhang; Yuxin Chen; Xuefan Yao; Ling Teng; Xinyuan Wang; Dafei Chai; Junnian Zheng; Gang Wang
Journal:  Hum Vaccin Immunother       Date:  2021-09-14       Impact factor: 4.526

Review 9.  High Mobility Group Box 1 in Human Cancer.

Authors:  Bernardo L Rapoport; Helen C Steel; Annette J Theron; Liezl Heyman; Teresa Smit; Yastira Ramdas; Ronald Anderson
Journal:  Cells       Date:  2020-07-10       Impact factor: 6.600

Review 10.  The Complex Relationship between Diabetic Retinopathy and High-Mobility Group Box: A Review of Molecular Pathways and Therapeutic Strategies.

Authors:  Marcella Nebbioso; Alessandro Lambiase; Marta Armentano; Giosuè Tucciarone; Vincenza Bonfiglio; Rocco Plateroti; Ludovico Alisi
Journal:  Antioxidants (Basel)       Date:  2020-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.